| Case study research in education V Timmons, E Cairns Encyclopedia of case study research 1, 99-102, 2010 | 143 | 2010 |
| The Cannabinoids Δ8THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation D Thapa, EA Cairns, AM Szczesniak, JT Toguri, MD Caldwell, MEM Kelly Cannabis and cannabinoid research 3 (1), 11-20, 2018 | 141 | 2018 |
| Access to cannabidiol without a prescription: A cross-country comparison and analysis IS McGregor, EA Cairns, S Abelev, R Cohen, M Henderson, D Couch, ... International Journal of Drug Policy 85, 102935, 2020 | 99 | 2020 |
| The endocannabinoid system as a therapeutic target in glaucoma EA Cairns, WH Baldridge, MEM Kelly Neural plasticity 2016 (1), 9364091, 2016 | 87 | 2016 |
| Positive allosteric modulation of the type 1 cannabinoid receptor reduces the signs and symptoms of Huntington's disease in the R6/2 mouse model RB Laprairie, AM Bagher, JL Rourke, A Zrein, EA Cairns, MEM Kelly, ... Neuropharmacology 151, 1-12, 2019 | 52 | 2019 |
| The fatty acid amide hydrolase inhibitor, URB597, promotes retinal ganglion cell neuroprotection in a rat model of optic nerve axotomy JE Slusar, EA Cairns, AM Szczesniak, HB Bradshaw, A Di Polo, ... Neuropharmacology 72, 116-125, 2013 | 48 | 2013 |
| Medicinal Cannabis Prescribing in Australia: An Analysis of Trends Over the First Five Years SL MacPhail, MA Bedoya-Pérez, R Cohen, V Kotsirilos, IS McGregor, ... Frontiers in Pharmacology 13, 2022 | 43 | 2022 |
| Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using … KE Grafinger, MM Vandeputte, A Cannaert, A Ametovski, E Sparkes, ... Drug testing and analysis 13 (7), 1412-1429, 2021 | 42 | 2021 |
| Allosteric cannabinoid receptor 1 (CB1) ligands reduce ocular pain and inflammation D Thapa, EA Cairns, AM Szczesniak, PM Kulkarni, AJ Straiker, GA Thakur, ... Molecules 25 (2), 417, 2020 | 42 | 2020 |
| Seeing over the horizon–targeting the endocannabinoid system for the treatment of ocular disease EA Cairns, JT Toguri, RF Porter, AM Szczesniak, MEM Kelly Journal of Basic and Clinical Physiology and Pharmacology 27 (3), 253-265, 2016 | 32 | 2016 |
| The In Vivo Effects of the CB1-Positive Allosteric Modulator GAT229 on Intraocular Pressure in Ocular Normotensive and Hypertensive Mice EA Cairns, AM Szczesniak, AJ Straiker, PM Kulkarni, RG Pertwee, ... Journal of Ocular Pharmacology and Therapeutics 33 (8), 582-590, 2017 | 31 | 2017 |
| Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using … E Pike, KE Grafinger, A Cannaert, A Ametovski, JL Luo, E Sparkes, ... Drug testing and analysis 13 (7), 1383-1401, 2021 | 29 | 2021 |
| Medicinal cannabis in the treatment of chronic pain LA Henderson, V Kotsirilos, EA Cairns, A Ramachandran, CC Peck, ... Australian Journal of General Practice 50 (10), 724-732, 2021 | 27 | 2021 |
| Structure–activity relationships of valine, tert-leucine, and phenylalanine amino acid-derived synthetic cannabinoid receptor agonists related to ADB-BUTINACA, APP-BUTINACA … E Sparkes, EA Cairns, RC Kevin, F Lai, KE Grafinger, S Chen, ... RSC Medicinal Chemistry 13 (2), 156-174, 2022 | 24 | 2022 |
| Frizzled 4 regulates ventral blood vessel remodeling in the zebrafish retina L Caceres, SV Prykhozhij, E Cairns, H Gjerde, NM Duff, K Collett, M Ngo, ... Developmental Dynamics 248 (12), 1243-1256, 2019 | 13 | 2019 |
| Why support a separate medical access framework for cannabis? EA Cairns, MEM Kelly CMAJ 189 (28), E927-E928, 2017 | 12 | 2017 |
| Medicinal Cannabis for Psychiatry-Related Conditions: An Overview of Current Australian Prescribing EA Cairns, MJ Benson, MA Bedoya-Perez, SL MacPhail, A Mohan, ... Frontiers in Pharmacology 14, 1381, 2023 | 11 | 2023 |
| Off-Target Pharmacological Profiling of Synthetic Cannabinoid Receptor Agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11 RC Kevin, EA Cairns, R Boyd, JC Arnold, MT Bowen, IS Mcgregor, ... Frontiers in Psychiatry, 2811, 2022 | 10 | 2022 |
| NNL-3: A Synthetic Intermediate or a New Class of Hydroxybenzotriazole Esters with Cannabinoid Receptor Activity? A Ametovski, EA Cairns, KE Grafinger, A Cannaert, MH Deventer, S Chen, ... ACS Chemical Neuroscience 12 (21), 4020-4036, 2021 | 8 | 2021 |
| Cannabichromene and Δ9-Tetrahydrocannabinolic Acid Identified as Lactate Dehydrogenase-A Inhibitors by in Silico and in Vitro Screening LJ Martin, EA Cairns, M Heblinski, C Fletcher, JR Krycer, JC Arnold, ... Journal of Natural Products 84 (5), 1469-1477, 2021 | 7 | 2021 |
Samuel D. BanisterResearch Scientist, Stanford UniversityVerified email at stanford.edu
